Alerts will be sent to your verified email
Verify Email
APL
|
Asston Pharma
|
Shelter Pharma
|
Bafna Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
31.69 % | 18.24 % | -52.11 % |
|
5yr average Equity Multiplier
|
5.73 | 1.33 | 3.77 |
|
5yr Average Asset Turnover Ratio
|
0.79 | 1.65 | 0.42 |
|
5yr Avg Net Profit Margin
|
10.83 % | 10.09 % | -36.55 % |
|
Price to Book
|
7.84 | 1.45 | 4.26 |
|
P/E
|
19.48 | 8.6 | 41.08 |
|
5yr Avg Cash Conversion Cycle
|
121.8 Days | 138.55 Days | 0.18 Days |
|
Inventory Days
|
31.3 Days | 71.81 Days | 87.65 Days |
|
Days Receivable
|
296.65 Days | 66.01 Days | 132.64 Days |
|
Days Payable
|
343.23 Days | 6.41 Days | 210.48 Days |
|
5yr Average Interest Coverage Ratio
|
3.57 | 84.13 | -5.68 |
|
5yr Avg ROCE
|
42.37 % | 25.47 % | -11.61 % |
|
5yr Avg Operating Profit Margin
|
15.11 % | 14.81 % | -21.98 % |
|
5 yr average Debt to Equity
|
1.99 | 0.03 | 1.41 |
|
5yr CAGR Net Profit
|
108.46 % | 182.84 % | 12.0 % |
|
5yr Average Return on Assets
|
7.75 % | 13.79 % | -16.11 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.66 % | 52.32 % | 75.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -4.57 % | -15.0 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Asston Pharma
|
Shelter Pharma
|
Bafna Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|